| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/11/2008 | CN101198319A Granular preparation containing biguanide compound |
| 06/11/2008 | CN101195613A Compound with substituted tetratomic ring structure and medicine use thereof |
| 06/11/2008 | CN101195612A Compound with substituted cyclobutane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN101195603A Novel crystal system of pitavastatin calcium and method for producing the same |
| 06/11/2008 | CN101195586A Compound with substituted cyclopentane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195585A Compound with substituted cyclohexane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195584A Compound with substituted cyclopropane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195012A Cordyceps sinensis medicine liqueur and preparing method |
| 06/11/2008 | CN101195001A Chinese medicine prescription for treating hypertension, hypercholesterolemia and hyperglycemia |
| 06/11/2008 | CN101194998A Chinese medicine for treating diabetes |
| 06/11/2008 | CN101194921A Persimmon leaf flavone extract, preparation method and application thereof |
| 06/11/2008 | CN101194913A Natural seal oil compression biological preparation for treating hyperlipidemia and technique of preparing the same |
| 06/11/2008 | CN101194900A Application of cinnamic aldehyde in alpha-glucosidase restrainer |
| 06/11/2008 | CN101194897A Method for preparing water-solubility compound vitamin microcapsule |
| 06/11/2008 | CN101194893A Dropping pills containing lovastatin and method for preparing the same |
| 06/11/2008 | CN101194890A Oral cavity rapid disintegrating tablet medicament and method of preparing the same |
| 06/11/2008 | CN101194738A Electrolyte beverage |
| 06/11/2008 | CN101194726A Movement nutrition food |
| 06/11/2008 | CN100393703C 1,2,3,4-tetrahydroisoquinoline derivatives |
| 06/11/2008 | CN100393334C A method for preparing fat-reducing medicine |
| 06/11/2008 | CN100393327C Chewing tablet of Taishan radix cynanchi bungei, its preparing method and use |
| 06/11/2008 | CN100393321C Oral antilipemic liquid and its preparing method |
| 06/11/2008 | CN100393320C Oligonucleotide medicine for treating myophagism |
| 06/11/2008 | CN100393309C Use of alpha-phenylthiocarboxylic and alpha-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 06/10/2008 | US7384982 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/10/2008 | US7384974 effective in reducing triglyceride levels in the liver and reducing blood glucose levels |
| 06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
| 06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
| 06/10/2008 | US7384965 Fused heterocyclic derivatives as PPAR modulators |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384943 Substituted chroman derivatives |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384920 Using a stilbene compound modified with hydroxy or alkoxy groups; antidiabetic agents; viricides |
| 06/10/2008 | US7384919 Nontoxic; spray drying or freeze drying |
| 06/10/2008 | US7384917 oligopeptides having renin suppression, diuretic and/or vasodilator activity in mammals; treating congestive heart failure |
| 06/10/2008 | US7384630 Harvesting pancrea tissue; grafting into body cavity; increase insulin concentration |
| 06/10/2008 | CA2431068C Crystalline forms of atorvastatin |
| 06/10/2008 | CA2429590C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2369070C 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/06/2008 | CA2609837A1 Composition and method for supporting thermogenesis and lipid oxidation |
| 06/05/2008 | WO2008067222A1 Heterocyclic modulators of tgr5 |
| 06/05/2008 | WO2008067219A2 Quinazolinone modulators of tgr5 |
| 06/05/2008 | WO2008066845A2 Treatment of metabolic syndrome with norfluoxetine |
| 06/05/2008 | WO2008066776A2 Methods for treating hypercholesterolemia |
| 06/05/2008 | WO2008066296A1 Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery system |
| 06/05/2008 | WO2008066295A1 Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system |
| 06/05/2008 | WO2008066199A1 Method of inducing differentiation of embryonic stem cells into insulin-secreting cells, insulin-secreting cells induced by the method and use of the same |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066131A1 Novel phenyl-isoxazol-3-ol derivative |
| 06/05/2008 | WO2008066117A1 Cyclic amine compound |
| 06/05/2008 | WO2008066097A1 Carboxylic acid derivative |
| 06/05/2008 | WO2008066070A1 Dipeptidyl peptidase-iv inhibitor |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008066026A1 Therapeutic agent for diabetes |
| 06/05/2008 | WO2008065796A1 α-GLUCOSIDASE INHIBITOR |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065624A1 Interaction partner of neuronatin protein and uses thereof |
| 06/05/2008 | WO2008065397A2 Assay |
| 06/05/2008 | WO2008065021A1 Diaminocyclohexane and diaminocyclopentane derivatives |
| 06/05/2008 | WO2008064615A2 Crystalline and amorphous forms of rimonabant and processes for obtaining them |
| 06/05/2008 | WO2008064474A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/05/2008 | WO2008064411A1 Nutritional supplement |
| 06/05/2008 | WO2008045378A3 Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin |
| 06/05/2008 | WO2008035206A3 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof |
| 06/05/2008 | WO2007098240B1 Compositions to reduce blood glucose levels and treat diabetes |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/05/2008 | US20080132566 Metabolic Syndrome-Improving Agent and Medicine, Supplement, Functional Food and Food Additive Containing the Same |
| 06/05/2008 | US20080132563 1-Thio-D-Glucitol Derivatives |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/05/2008 | US20080132560 fluvastatin sodium and a polymer in a solidified form of an at least partially liquid dispersion solution; allows a zero-order drug release over a prolonged period of time |
| 06/05/2008 | US20080132554 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 06/05/2008 | US20080132553 Preventing and reversing the formation of advance glycosylation endproducts |
| 06/05/2008 | US20080132544 Peroxisome Proliferator-Activated Receptor Ligand |
| 06/05/2008 | US20080132542 [5-(5-{4-[2-(Trifluoromethyl)phenoxy]piperidin-1-yl}-1,3,4-thiadiazol-2-yl)-2H-tetrazol-2-yl]acetic acid; metabolic disorders,antidiabetic, hypoglycemic agent; obesity, insulin resistance, liver steatosis, atherosclerosis, neurological disease, dyslipidemia, hyperlipidemia, low HDL, and high LDL |
| 06/05/2008 | US20080132540 Such as trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-N-(1-benzyl-piperidin-4-yl)-3-phenyl-acrylamide; for treating/preventing anxiolytic disorders/depression, injured mammalian nerve tissue, conditions, neurological disorders, bone loss, substance related disorders, and obesity; neuropeptide y (NPY Y2) |
| 06/05/2008 | US20080132521 Isoquinolinone Derivatives and Their Use As Therapeutic Agents |
| 06/05/2008 | US20080132519 nuclear receptor activity modulators; 4-(ethylamino)-3-{[(2Z,5Z)-5-{[methyl(phenyl)amino]methylidene}-4-oxo-3-(phenylmethyl)-1,3-thiazolidin-2-ylidene]amino}benzonitrile; diseases or disorders affected by abnormal cholesterol, triglyceride, or bile acid levels |
| 06/05/2008 | US20080132483 Administering (3R,5S)-N-propanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetamide; cerebral infarction |
| 06/05/2008 | US20080132479 Oxime Derivative and Preparations Thereof |
| 06/05/2008 | US20080132466 Difructose anhydride and an isoflavone |
| 06/05/2008 | US20080132460 Screening for a compound which inhibits p62/ubiquitin binding; detecting the formation of inclusion bodies in neurodegenerative diseases; screening for therapeutic agents that disperse the inclusions |
| 06/05/2008 | US20080132440 Vitamin D or vitamin C complex with polyglutamic acid; improved stability; food, beverage, cosmetic; esterification |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids |
| 06/05/2008 | US20080131536 Fermenting licorice root and sodium carbonate in warm water, adding diluted HCl followed by stirring, filtering |
| 06/05/2008 | US20080131534 Use of a plant extract or plant juice |
| 06/05/2008 | US20080131531 Konjac Mannan and Ginseng Compositions and Methods and Uses Thereof |